Testing a needle-less device to reduce blood culture contamination
Part of Infections clinical trials.
This study tests a device called PIVO to see if it can reduce contamination when taking blood samples to check for bloodstream infections. If you need a blood culture (a test to find germs in your blood) and have a small IV line (22 gauge or larger), you may be able to join this study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be able to have a blood culture done to check for a possible infection in your bloodstream.
- You must have a short IV catheter (22 gauge or larger) already in place.
- You cannot have started receiving antibiotics through your IV in the emergency department.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called PIVO that may make it easier and less painful to draw blood for blood cultures in the emergency room. It's for anyone in the ER who needs this test.
This study looks at the bacteria that can build up on IV lines to see if they increase the risk of infection. By examining these bacteria, researchers hope to find ways to reduce infections in patients who need IV treatment.
This trial is testing a new way to draw blood from an arterial line that may reduce infection and blood loss. It is for adults in the ICU who need an arterial line for several days.
This trial tests whether a machine learning model can help doctors decide when to order blood cultures for patients in the emergency department. It aims to reduce unnecessary tests while still catching infections.
This study tests a way of cleaning the biopsy needle during a prostate biopsy to reduce infection risk. If you are having a prostate biopsy, this approach may help lower the chance of infection.
This study looks at whether taking blood cultures from an arterial line (a small tube in an artery) gives more accurate results and is less likely to have false positives compared to how blood is usually drawn. It may help improve how infections are detected in ICU patients.
Hear when a new Blood Culture Contamination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.